English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [709]
News [2443]
Articles [199]
Editorials [6]
Conferences [89]
elearning [31]
Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives
Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives
Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus cancers
Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus...
FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma
FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma
More than 10% of samples from a stool-based colorectal cancer test may be unsatisfactory
More than 10% of samples from a stool-based colorectal cancer test may be unsatisfactory
Some increase in cancer after 1986 Chernobyl disaster
Some increase in cancer after 1986 Chernobyl disaster
FDA amends pembrolizumab’s gastric cancer indication
FDA amends pembrolizumab’s gastric cancer indication
FDA approves pembrolizumab with chemotherapy for biliary tract cancer
FDA approves pembrolizumab with chemotherapy for biliary tract cancer
Does diabetes affect the survival of individuals with colorectal cancer?
Does diabetes affect the survival of individuals with colorectal cancer?
Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at high-risk of recurrence
Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at...
ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds
ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds
<1...2627282930...245>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top